May 14: The Week in Cancer News
Study suggests ovarian cancer screening does not reduce mortality, and more news of the week from Cancer Today.
Progress Against Cancer
Study suggests ovarian cancer screening does not reduce mortality, and more news of the week from Cancer Today.
Since 2014, the American Association for Cancer Research (AACR) has invited early-career investigators to apply to the NextGen Stars program, which provides awardees the opportunity to present their research on a global stage at the AACR Annual Meeting. The enhanced visibility granted by the NextGen Stars program has...
A Food and Drug Administration panel recommends withdrawing approvals for two treatment indications for immunotherapy drugs, and more news of the week from Cancer Today.
Many patients facing a cancer diagnosis ask their doctors a simple question: “What should I eat?” That elemental question has perplexed scientists for centuries. In a stirring discussion during the Opening Plenary session of...
President Biden resurfaces a proposal for a new health care agency, and more news of the week from Cancer Today.
Scientists discussed the mechanisms of chemotherapy-related cognitive impairment at a session dedicated to symptom science at the AACR Annual Meeting 2021.
Immunotherapy has revolutionized cancer treatment over the past decade, providing potentially lifesaving therapies to many patients who otherwise would have limited options. Despite its success for many patients, immunotherapy still has challenges to overcome. Fortunately, novel strategies to improve the efficacy...
The immune systems of people with blood cancer respond differently to the coronavirus than the immune systems of people without cancer.
A study indicates that people are delaying medical care until they are eligible for Medicare, and more news of the week from Cancer Today.
Underrepresentation of members of minority groups in public genomic databases could lead to misleading test results, and more news of the week from Cancer Today.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now